Abbvie Inc Stock Probability Of Bankruptcy
ABBV34 Stock | BRL 51.85 0.06 0.12% |
AbbVie |
AbbVie Inc Company chance of distress Analysis
AbbVie's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current AbbVie Probability Of Bankruptcy | Less than 9% |
Most of AbbVie's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AbbVie Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of AbbVie probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting AbbVie odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of AbbVie Inc financial health.
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition |
Based on the latest financial disclosure, AbbVie Inc has a Probability Of Bankruptcy of 9.0%. This is 79.21% lower than that of the Healthcare sector and 78.12% lower than that of the Drug Manufacturers - Major industry. The probability of bankruptcy for all Brazil stocks is 77.4% higher than that of the company.
AbbVie Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbbVie's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbbVie could also be used in its relative valuation, which is a method of valuing AbbVie by comparing valuation metrics of similar companies.AbbVie is currently under evaluation in probability of bankruptcy category among related companies.
AbbVie Fundamentals
Return On Equity | 0.75 | |||
Return On Asset | 0.0927 | |||
Profit Margin | 0.20 % | |||
Operating Margin | 0.39 % | |||
Current Valuation | 1.85 T | |||
Shares Outstanding | 28.3 B | |||
Price To Earning | 92.88 X | |||
Price To Book | 18.25 X | |||
Price To Sales | 26.35 X | |||
Revenue | 58.05 B | |||
Gross Profit | 41.49 B | |||
EBITDA | 31.08 B | |||
Net Income | 4.09 B | |||
Cash And Equivalents | 5.23 B | |||
Cash Per Share | 3.54 X | |||
Total Debt | 37.92 B | |||
Current Ratio | 1.04 X | |||
Book Value Per Share | 9.04 X | |||
Cash Flow From Operations | 13.8 B | |||
Earnings Per Share | 2.18 X | |||
Number Of Employees | 26 | |||
Beta | 0.58 | |||
Market Capitalization | 1.42 T | |||
Z Score | 22.2 | |||
Annual Yield | 0.04 % | |||
Last Dividend Paid | 5.71 |
About AbbVie Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AbbVie Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbbVie using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbbVie Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for AbbVie Stock analysis
When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |